DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹50 Cr | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr | ₹1,987 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹50 Cr |
Mar2024 | ₹193 Cr |
Mar2023 | ₹-1,045 Cr |
Mar2022 | ₹-816 Cr |
Mar2021 | ₹1,987 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹50 Cr | -74.09 | |
Mar2024 | ₹193 Cr | Positive | |
Mar2023 | ₹-1,045 Cr | Negative | |
Mar2022 | ₹-816 Cr | Negative | |
Mar2021 | ₹1,987 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹175,053.4 Cr | 0.3% | 6.4% | 8.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,560.0 Cr | 2.2% | 2.1% | -10.7% | Stock Analytics | |
CIPLA | ₹134,400.0 Cr | 6.8% | 5.6% | 5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,507.0 Cr | 1.6% | -1.1% | 5.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,628.0 Cr | 4.6% | -2.5% | -4.3% | Stock Analytics | |
MANKIND PHARMA | ₹100,992.0 Cr | 0% | -8.1% | -8.5% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 0.3% |
6.4% |
8.7% |
SENSEX | 2.9% |
1.7% |
3.6% |
You may also like the below Video Courses